Cargando…

Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis

BACKGROUND: A meta-analysis concluded that there was no effect of the femoral head ossification and the incidence of osteonecrosis in the treatment of developmental dysplasia of the hip (DDH), unless only osteonecrosis grades II-IV were considered. The meta-analysis, limited due to the small number...

Descripción completa

Detalles Bibliográficos
Autores principales: Niziol, Rafal, Elvey, Michael, Protopapa, Evangelia, Roposch, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397826/
https://www.ncbi.nlm.nih.gov/pubmed/28427427
http://dx.doi.org/10.1186/s12891-017-1468-6
_version_ 1783230346069803008
author Niziol, Rafal
Elvey, Michael
Protopapa, Evangelia
Roposch, Andreas
author_facet Niziol, Rafal
Elvey, Michael
Protopapa, Evangelia
Roposch, Andreas
author_sort Niziol, Rafal
collection PubMed
description BACKGROUND: A meta-analysis concluded that there was no effect of the femoral head ossification and the incidence of osteonecrosis in the treatment of developmental dysplasia of the hip (DDH), unless only osteonecrosis grades II-IV were considered. The meta-analysis, limited due to the small number of studies available at that time, identified a need for an update as further research emerges. We observed a trend in recent years towards delaying treatment of DDH in the absence of an ossified nucleus. Numerous new publications on this topic encouraged us to update the 2009 meta-analysis. METHODS: We performed a systematic review of the literature from 1967 to 2016 and included studies that reported on the treatment of DDH, the ossific nucleus and osteonecrosis. Two independent reviewers evaluated all articles. We performed a meta-analysis with the main outcome defined as the development of osteonecrosis of the femoral head at least two years after closed or open reduction. RESULTS: Of four prospective and ten retrospective studies included in the systematic review, 11 studies (1,021 hips) met the inclusion criteria for the meta-analysis. There was no significant effect of the ossific nucleus on the development of all grades of osteonecrosis (relative risk, 0.88; 95% confidence interval, 0.56–1.41) or osteonecrosis grades II–IV (0.67; 0.41–1.08). In closed reductions, the ossific nucleus halved the risk for developing osteonecrosis grades II–IV (0.50; 0.26–0.94). CONCLUSIONS: Based on current evidence there does not appear to be a protective effect of the ossific nucleus on the development of osteonecrosis. In contrast to the previous meta-analysis, this update demonstrates that this remains the case irrespective of the grade of osteonecrosis considered relevant. This updated meta-analysis is based on twice as many studies with a higher quality of evidence. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12891-017-1468-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5397826
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53978262017-04-21 Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis Niziol, Rafal Elvey, Michael Protopapa, Evangelia Roposch, Andreas BMC Musculoskelet Disord Research Article BACKGROUND: A meta-analysis concluded that there was no effect of the femoral head ossification and the incidence of osteonecrosis in the treatment of developmental dysplasia of the hip (DDH), unless only osteonecrosis grades II-IV were considered. The meta-analysis, limited due to the small number of studies available at that time, identified a need for an update as further research emerges. We observed a trend in recent years towards delaying treatment of DDH in the absence of an ossified nucleus. Numerous new publications on this topic encouraged us to update the 2009 meta-analysis. METHODS: We performed a systematic review of the literature from 1967 to 2016 and included studies that reported on the treatment of DDH, the ossific nucleus and osteonecrosis. Two independent reviewers evaluated all articles. We performed a meta-analysis with the main outcome defined as the development of osteonecrosis of the femoral head at least two years after closed or open reduction. RESULTS: Of four prospective and ten retrospective studies included in the systematic review, 11 studies (1,021 hips) met the inclusion criteria for the meta-analysis. There was no significant effect of the ossific nucleus on the development of all grades of osteonecrosis (relative risk, 0.88; 95% confidence interval, 0.56–1.41) or osteonecrosis grades II–IV (0.67; 0.41–1.08). In closed reductions, the ossific nucleus halved the risk for developing osteonecrosis grades II–IV (0.50; 0.26–0.94). CONCLUSIONS: Based on current evidence there does not appear to be a protective effect of the ossific nucleus on the development of osteonecrosis. In contrast to the previous meta-analysis, this update demonstrates that this remains the case irrespective of the grade of osteonecrosis considered relevant. This updated meta-analysis is based on twice as many studies with a higher quality of evidence. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12891-017-1468-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-20 /pmc/articles/PMC5397826/ /pubmed/28427427 http://dx.doi.org/10.1186/s12891-017-1468-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Niziol, Rafal
Elvey, Michael
Protopapa, Evangelia
Roposch, Andreas
Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis
title Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis
title_full Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis
title_fullStr Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis
title_full_unstemmed Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis
title_short Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis
title_sort association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the hip: updated meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397826/
https://www.ncbi.nlm.nih.gov/pubmed/28427427
http://dx.doi.org/10.1186/s12891-017-1468-6
work_keys_str_mv AT niziolrafal associationbetweentheossificnucleusandosteonecrosisintreatingdevelopmentaldysplasiaofthehipupdatedmetaanalysis
AT elveymichael associationbetweentheossificnucleusandosteonecrosisintreatingdevelopmentaldysplasiaofthehipupdatedmetaanalysis
AT protopapaevangelia associationbetweentheossificnucleusandosteonecrosisintreatingdevelopmentaldysplasiaofthehipupdatedmetaanalysis
AT roposchandreas associationbetweentheossificnucleusandosteonecrosisintreatingdevelopmentaldysplasiaofthehipupdatedmetaanalysis